T 1258/16 (Abiraterone prednisone combination for treatment of prostate cancer/JANSSEN) of 06.02.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T125816.20200206
- Date of decision
- 6 February 2020
- Case number
- T 1258/16
- Petition for review of
- -
- Application number
- 07837326.3
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Compositions for treating cancer
- Applicant name
- Janssen Oncology, Inc.
- Opponent name
- Alfred E. Tiefenbacher (GmbH & Co. KG)
Helm AG
Laboratorios Léon Farma, S.A.
STADA Arzneimittel AG
Hetero Drugs Ltd.
CABINET LAVOIX
Synthon B.V./Genthon B.V.
Galenicum Health S.L.
Teva Pharmaceutical Industries LTD.
Maiwald Patent- und Rechtsanwaltsgesellschaft mbH
Generics [UK] Limited
Actavis Group PTC ehf
Gallafent, Alison
Patentanwälte Isenbruck Bösl Hörschler PartG mbB
Zentiva k.s. - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
- Catchword
- -
- Citing cases
- T 0777/15
Order
For these reasons it is decided that:
The appeal proceedings are terminated.